HIV Treatment Breakthrough Discovered by Israeli Scientists

Advertisement

As HIV transmission is reported to be “out of control” among gay men in France, Israeli researchers offer hope against the spread of the AIDS virus. A new treatment discovered at the Hebrew University’s Alexander Silberman Institute of Life Sciences and the Institute of Chemistry may have the ability to destroy HIV-infected human cells without damaging healthy ones.

Treatment Causes Infected Cells to Self-Destruct

Currently, there is no cure for AIDS, however current treatments have been developed to delay the development of the disease and make it more manageable. The new treatment fights HIV by causing infected cells to “self-destruct”, says Dr. Abraham Loyter who published his findings in the British journal AIDS Research and Therapy.

Advertisement

When the Human Immunodeficiency Virus (HIV) enters a cell, its DNA replicates which manufactures new virus that infects surrounding cells. The peptide treatment discovered by Dr. Loyter and his colleagues will interfere with this genetic replication by transmitting a signal to kill the infected cell. In human cell laboratory cultures, the infected cells disappeared in two weeks and did not reappear up to two weeks later.

The treatment developed by the team was patented earlier this year and they plan to start animal and human trials soon.

It is estimated that about 33 million people worldwide are carriers of HIV with the majority of those affected living in Sub-Saharan Africa. In the US, one million are estimated to be living with the virus while another half million have died. The latest figures from France, reported in the Lancet Infectious Disease journal, has found that 7,000 new cases of HIV were diagnosed in 2008 in France, nearly half of those in homosexual men.

Other Recent HIV/AIDS News:
Vaginal Gel Reduces HIV Risk
Earlier Antiretroviral Therapy Cuts HIV Patients Risk of Death
Vienna 2010 HIV/AIDS Conference Focuses on Prevention

Advertisement

Comments

is this another promise?
The publication is of 2010, please give me the current status of the medication made by the Israeli scientists. If I want to be one of the patient from Africa to whom the trial/test of the medication can be done, what procedures should be followed?